A share price of Cytosorbents Corp [CTSO] is currently trading at $0.79, down -5.47%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CTSO shares have gain 23.83% over the last week, with a monthly amount drifted -5.41%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cytosorbents Corp [NASDAQ: CTSO] stock has seen the most recent analyst activity on September 07, 2023, when B. Riley Securities initiated its Buy rating and assigned the stock a price target of $4. On September 17, 2020, Jefferies initiated with a Buy rating and assigned a price target of $15 on the stock. SVB Leerink started tracking the stock assigning a Outperform rating and suggested a price target of $15 on September 01, 2020. Maxim Group reiterated its recommendation of a Buy and raised its price target to $12 on August 08, 2017. In a note dated May 24, 2016, Maxim Group initiated an Buy rating and provided a target price of $8 on this stock.
Cytosorbents Corp experienced fluctuations in its stock price throughout the past year between $0.60 and $1.61. Cytosorbents Corp [NASDAQ: CTSO] shares were valued at $0.79 at the most recent close of the market.
Analyzing the CTSO fundamentals
Trailing Twelve Months sales for Cytosorbents Corp [NASDAQ:CTSO] were 34.35M which represents 1.01% growth. Gross Profit Margin for this corporation currently stands at 0.77% with Operating Profit Margin at -0.42%, Pretax Profit Margin comes in at -0.37%, and Net Profit Margin reading is -0.31%. To continue investigating profitability, this company’s Return on Assets is posted at -0.23, Equity is -0.92 and Total Capital is -0.4. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of3.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.7743 points at the first support level, and at 0.7577 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.8233, and for the 2nd resistance point, it is at 0.8557.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Cytosorbents Corp [NASDAQ:CTSO] is 2.11. As well, the Quick Ratio is 1.71, while the Cash Ratio is 0.75. Considering the valuation of this stock, the price to sales ratio is 1.45, the price to book ratio is 5.51.
Transactions by insiders
Recent insider trading involved MARIANI PETER J, Officer, that happened on Aug 19 ’25 when 10548.0 shares were purchased. Chief Financial Officer, MARIANI PETER J completed a deal on Dec 13 ’24 to buy 20000.0 shares. Meanwhile, Chief Financial Officer MARIANI PETER J bought 20000.0 shares on Dec 12 ’24.
